Clinical Trial: Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria

U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07235020) titled 'Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria' on Nov. 14.

Brief Summary: This is Cohort A1 of the Platform study (NCT05750628) to evaluate the efficacy and safety of INE963 in participants with uncomplicated Plasmodium falciparum malaria.

Study Start Date: Jan. 23, 2024

Study Type: INTERVENTIONAL

Condition: Uncomplicated Plasmodium Falciparum Malaria

Intervention: DRUG: INE963

Administered via oral INE963

Recruitment Status: COMPLETED

Sponsor: Novartis Pharmaceuticals

Disclaimer: Curated by HT Syndication....